Omeprazole Blocks STAT6 Binding to the Eotaxin-3 Promoter in Eosinophilic Esophagitis Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Zhang, Xi ^a   Cheng, Edaire ^a   Huo, Xiaofang ^a   Yu, Chunhua ^a   Zhang, Qiuyang ^a   Pham, Thai H ^a   Wang, David H ^a,b   Spechler, Stuart J ^a   Souza, Rhonda F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN 3; HISTONE H3; INTERLEUKIN 4; LANSOPRAZOLE; MESSENGER RNA; OMEPRAZOLE; RNA POLYMERASE II; STAT6 PROTEIN; TELOMERASE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; EOSINOPHILIC ESOPHAGITIS; EPITHELIUM CELL; ESOPHAGUS CELL; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RNA STABILITY; SQUAMOUS CELL;

CELL CULTURE TECHNIQUES; CHEMOKINES, CC; DNA-BINDING PROTEINS; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; GASTRIC ACID; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-4; OMEPRAZOLE; PROMOTER REGIONS, GENETIC; PROTON PUMP INHIBITORS; RNA POLYMERASE II; STAT6 TRANSCRIPTION FACTOR;

EID: 84869853129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050037     Document Type: Article

References (34)

1. Kahrilas PJ, Shaheen NJ, Vaezi MF (2008) American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology, 135, 1392-1413, 1413.
2. Shin JM, Sachs G (2008) Pharmacology of proton pump inhibitors. Curr. Gastroenterol. Rep., 10, 528-534.
3. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, et al. (2006) Pharmacological interventions for non-ulcer dyspepsia. Cochrane. Database. Syst. Rev., CD001960.
4. Kahrilas PJ, Hughes N, Howden CW (2011) Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Gut, 60, 1473-1478.
5. Kedika RR, Souza RF, Spechler SJ (2009) Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig. Dis. Sci., 54, 2312-2317.
6. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, et al. (2011) Eosinophilic esophagitis: updated consensus recommendations for children and adults. J.Allergy Clin. Immunol., 128, 3-20.
7. Spechler SJ, Genta RM, Souza RF (2007) Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am. J. Gastroenterol., 102, 1301-1306.
8. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, et al. (2007) Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology, 133, 1342-1363.
9. Ngo P, Furuta GT, Antonioli DA, Fox VL (2006) Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am. J. Gastroenterol., 101, 1666-1670.
10. Molina-Infante J, Ferrando-Lamana L, Ripoll C, Hernandez-Alonso M, Mateos JM, et al. (2011) Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin. Gastroenterol. Hepatol., 9, 110-117.
11. Blanchard C, Durual S, Estienne M, Emami S, Vasseur S, et al. (2005) Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6. Int. J. Biochem. Cell Biol., 37, 2559-2573.
12. Hebenstreit D, Luft P, Schmiedlechner A, Duschl A, Horejs-Hoeck J (2005) SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells. Mol. Immunol., 42, 295-303.
13. Hoeck J, Woisetschlager M (2001) Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6. J. Immunol., 167, 3216-3222.
14. Cheng E, Zhang X, Huo X, Yu C, Zhang Q, et al. (2012) Omeprazole Blocks Eotaxin-3 Expression by Oesophageal Squamous Cells from Patients with Eosinophilic Oesophagitis and GORD. Gut, in press.
15. Zhang HY, Zhang X, Chen X, Thomas D, Hormi-Carver K,et al. (2008) Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus. Am. J. Physiol Gastrointest. Liver Physiol, 295, G470-G478.
16. Cortes JR, Rivas MD, Molina-Infante J, Gonzalez-Nunez MA, Perez G, et al. (2009) Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma. J. Allergy Clin. Immunol., 124, 607-10, 610.
17. Nelson JD, Denisenko O, Bomsztyk K (2006) Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc., 1, 179-185.
18. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, Duschl A (2006) Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev., 17, 173-188.
19. Smith CL, Hager GL (1997) Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J. Biol. Chem., 272, 27493-27496.
20. Goenka S, Marlar C, Schindler U, Boothby M (2003) Differential roles of C-terminal activation motifs in the establishment of Stat6 transcriptional specificity. J. Biol. Chem., 278, 50362-50370.
21. Berger SL (2007) The complex language of chromatin regulation during transcription. Nature, 447, 407-412.
22. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell, 129, 823-837.
23. Glover-Cutter K, Kim S, Espinosa J, Bentley DL (2008) RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes. Nat. Struct. Mol. Biol., 15, 71-78.
24. Fais S, De Milito A, You H, Qin W (2007) Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res., 67, 10627-10630.
25. Li XQ, Andersson TB, Ahlstrom M, Weidolf L (2004) Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos., 32, 821-827.
26. Cederberg C, Thomson AB, Mahachai V, Westin JA, Kirdeikis P, et al. (1992) Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients. Gastroenterology, 103, 913-918.
27. Kurashima K, Numata M, Yachie A, Sai Y, Ishizaka N, et al. (1996) The role of vacuolar H(+)-ATPase in the control of intragranular pH and exocytosis in eosinophils. Lab Invest, 75, 689-698.
28. Lafourcade C, Sobo K, Kieffer-Jaquinod S, Garin J, van der Goot FG (2008) Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization. PLoS. One., 3, e2758.
29. Bankers-Fulbrigh JL, Kephart GM, Bartemes KR, Kita H, O'Grady SM (2004) Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils. J. Cell Sci., 117, 5749-5757.
30. Dubos RJ (1955) The micro-environment of inflammation or Metchnikoff revisited. Lancet, 269, 1-5.
31. Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, et al. (2000) Endogenous airway acidification. Implications for asthma pathophysiology. Am. J. Respir. Crit Care Med., 161, 694-699.
32. Ward TT, Steigbigel RT (1978) Acidosis of synovial fluid correlates with synovial fluid leukocytosis. Am. J. Med., 64, 933-936.
33. Tobey NA, Koves G, Orlando RC (1998) Human esophageal epithelial cells possess an Na+/H+ exchanger for H+ extrusion. Am. J. Gastroenterol., 93, 2075-2081.
34. Perez G, Cortes JR, Rivas MD, Masa F, Zamorano J (2008) Treatment of cells with n-alpha-tosyl-L-phenylalanine-chloromethyl ketone induces the proteolytic loss of STAT6 transcription factor. Mol. Immunol., 45, 3896-3901.